The significance of FOXP1 in diffuse large B-cell lymphoma
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of mature B-cell lymphoma. While the majority of patients are cured with immunochemotherapy incorporating the anti-CD20 monoclonal antibody rituximab (R-CHOP), relapsed and refractory patients still have a dismal prognosis. DLBCL subty...
| Autors principals: | , |
|---|---|
| Format: | Journal article |
| Publicat: |
Taylor and Francis
2016
|